Medical Market Report

Global Controlled-Release Drug Delivery Systems Market By Type (Wurster Technique, Coacervation, Micro Encapsulation, Implants, Transdermal, Targeted Delivery, and Others), By Application (Metered Dose Inhalers, Injectables, Transdermal and Ocular Patches, Infusion Pumps, Oral Controlled-Drug Delivery Systems, Drug Eluting Stents, and Other), By Region, and Key Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2020-2029

  • 138406
  • 18-Dec
  • PDF/PPT/Word
  • ★ ★ ★ ★ ★
    ★ ★ ★ ★ ★
  • Report Details

    Global Controlled-Release Drug Delivery Systems Market is estimated to be valued US$ XX.X million in 2019. The report on Controlled-Release Drug Delivery Systems Market provides qualitative as well as quantitative analysis in terms of market dynamics, competition scenarios, opportunity analysis, market growth, etc. for the forecast year up to 2029. The global controlled-release drug delivery systems market is segmented on the basis of Type, Application, and geography.

    Europe market was valued at US$ XX.X million in 2018 and is projected to reach US$ XX.X million in 2029, and register a CAGR of X.X% during the forecast period, according to a new Market.us (Prudour Research) study.

    Controlled-Release Drug Delivery Systems Market Scope:

    By type, the market is segmented into Wurster Technique, Coacervation, Micro Encapsulation, Implants, Transdermal, Targeted Delivery, and Others. By Application, the market is divided into Metered Dose Inhalers, Injectables, Transdermal and Ocular Patches, Infusion Pumps, Oral Controlled-Drug Delivery Systems, Drug Eluting Stents, and Other.
    Based on geography, the market is analyzed across North America, Europe, Asia-Pacific, Latin America, and Middle East and Africa. Major players profiled in the report include Depomed Inc., Coating Place Inc., Corium International Inc., Johnson and Johnson, Alkermes plc, Pfizer Inc., Orbis Biosciences Inc., Capsugel, Merck and Co. Inc., and Aradigm Corporation.

    Key Market Segments

    Type

    Wurster Technique

    Coacervation

    Micro Encapsulation

    Implants

    Transdermal

    Targeted Delivery

    Others

    Application

    Metered Dose Inhalers

    Injectables

    Transdermal and Ocular Patches

    Infusion Pumps

    Oral Controlled-Drug Delivery Systems

    Drug Eluting Stents

    Other

    Key Market Players included in the report:

    Depomed Inc.

    Coating Place Inc.

    Corium International Inc.

    Johnson and Johnson

    Alkermes plc

    Pfizer Inc.

    Orbis Biosciences Inc.

    Capsugel

    Merck and Co. Inc.

    Aradigm Corporation

    Reasons to Get this Report:

    In an insight outlook, this research report has dedicated to several quantities of analysis – industry research (global industry trends) and Controlled-Release Drug Delivery Systems Market share analysis of high players, along with company profiles, and which collectively include about the fundamental opinions regarding the market landscape; emerging and high-growth sections of Controlled-Release Drug Delivery Systems Market; high-growth regions; and market drivers, restraints, and also market chances.
    The analysis covers Controlled-Release Drug Delivery Systems Market and its advancements across different industry verticals as well as regions. It targets estimating the current market size and growth potential of the global Controlled-Release Drug Delivery Systems Market across sections such as also Application and representatives.
    Additionally, the analysis also has a comprehensive review of the crucial players on the Controlled-Release Drug Delivery Systems Market together side their company profiles, SWOT analysis, latest advancements, and business plans.

    The analysis objectives of the report are:

    To equitably share in-depth info regarding the crucial elements impacting the increase of industry (growth capacity, chances, drivers, and industry-specific challenges and risks).
    To know the Controlled-Release Drug Delivery Systems Market by pinpointing its many subsegments.
    To profile the important players and analyze their growth plans.
    To endeavor the amount and value of Controlled-Release Drug Delivery Systems sub-markets, depending on key regions (various vital states).
    To analyze Controlled-Release Drug Delivery Systems Market concerning growth trends, prospects, and also their participation in the entire sector.
    To examine and study the Controlled-Release Drug Delivery Systems Market size (volume & value) from the company, essential regions/countries, products, and Application, background information from 2013 to 2018, and also prediction to 2029.
    Primary worldwide Controlled-Release Drug Delivery Systems Market manufacturing companies, to specify, clarify and analyze the product sales amount, value and market share, market rivalry landscape, SWOT analysis and development plans next coming years.
    To examine competitive progress such as expansions, arrangements, new product launches, and acquisitions on the market.

  • Table Of Content 
    1. Controlled-Release Drug Delivery Systems Market Introduction
    

    1.1. Definition
    
1.2. Taxonomy
    
1.3. Research Scope
    

    2. Executive Summary
    

      2.1. Key Findings by Major Segments
    
  2.2. Top strategies by Major Players
    

    3. Global Controlled-Release Drug Delivery Systems Market Overview
    

    3.1. Controlled-Release Drug Delivery Systems Market Dynamics
    

        3.1.1. Drivers
    
    3.1.2. Opportunities
    
    3.1.3. Restraints
    
    3.1.4. Challenges
    

      3.2. PESTLE Analysis
    
  3.3. Opportunity Map Analysis
    
  3.4. PORTER’S Five Forces Analysis
    
  3.5. Market Competition Scenario Analysis
    
  3.6. Product Life Cycle Analysis
    
  3.7. Opportunity Orbits
    
  3.8. Production Analysis by Region/Company
    
  3.9. Industry chain Analysis
    
  3.10. Marketing Strategy
    

    4. Global Controlled-Release Drug Delivery Systems Market Value & Volume ((US$ Mn & ‘000 Units)), Share (%), and Growth Rate (%) Comparison by Type, 2012-2028
    

      4.1. Global Controlled-Release Drug Delivery Systems Market Analysis by Type: Introduction
    
  4.2. Market Size and Forecast by Region
    
  4.3. Wurster Technique
    

      4.4. Coacervation
    

      4.5. Micro Encapsulation
    

      4.6. Implants
    

      4.7. Transdermal
    

      4.8. Targeted Delivery
    

      4.9. Others
    

    5. Global Controlled-Release Drug Delivery Systems Market Value & Volume ((US$ Mn & ‘000 Units)), Share (%), and Growth Rate (%) Comparison by Application, 2012-2028
    

      5.1. Global Controlled-Release Drug Delivery Systems Market Analysis by Application: Introduction
    
  5.2. Market Size and Forecast by Region
    
  5.3. Metered Dose Inhalers
    

      5.4. Injectables
    

      5.5. Transdermal and Ocular Patches
    

      5.6. Infusion Pumps
    

      5.7. Oral Controlled-Drug Delivery Systems
    

      5.8. Drug Eluting Stents
    

      5.9. Other
    

    6. Global Controlled-Release Drug Delivery Systems Market Value & Volume ((US$ Mn & ‘000 Units)), Share (%), and Growth Rate (%) Comparison by Region, 2012-2028
    

      6.1. North America
    

        6.1.1. North America Controlled-Release Drug Delivery Systems Market: Regional Trend Analysis
    

         6.1.1.1. US
    
     6.1.1.2. Canada
    
     6.1.1.3. Mexico
    

      6.2.1. Europe
    

        6.2.1. Europe Controlled-Release Drug Delivery Systems Market: Regional Trend Analysis
    

         6.2.1.1. Germany
    
     6.2.1.2. France
    
     6.2.1.3. UK
    
     6.2.1.4. Russia
    
     6.2.1.5. Italy
    
     6.2.1.6. Spain
    
     6.2.1.7. Rest of Europe
    

      6.3. Asia-Pacific
    

        6.3.1. Asia-Pacific Controlled-Release Drug Delivery Systems Market: Regional Trend Analysis
    

         6.3.1.1. China
    
     6.3.1.2. Japan
    
     6.3.1.3. Korea
    
     6.3.1.4. India
    
     6.3.1.5. Rest of Asia-Pacific
    

      6.4. Latin America
    

        6.4.1. Latin America Controlled-Release Drug Delivery Systems Market: Regional Trend Analysis
    

         6.4.1.1. Brazil
    
     6.4.1.2. Argentina
    
     6.4.1.3. Rest of Latin America
    

      6.5. Middle East and Africa
    

        6.5.1. Middle East and Africa Controlled-Release Drug Delivery Systems Market: Regional Trend Analysis
    

         6.5.1.1. GCC
    
     6.5.1.2. South Africa
    
     6.5.1.3. Israel
    
     6.5.1.4. Rest of MEA
    

    7. Global Controlled-Release Drug Delivery Systems Market Competitive Landscape, Market Share Analysis, and Company Profiles
    

      7.1. Market Share Analysis
    
  7.2. Company Profiles
    
  7.3. Depomed#Inc.
    

        7.3.1. Company Overview
    
    7.3.2. Financial Highlights
    
    7.3.3. Product Portfolio
    
    7.3.4. SWOT Analysis
    
    7.3.5. Key Strategies and Developments
    

      7.4. Coating Place#Inc.
    

        7.4.1. Company Overview
    
    7.4.2. Financial Highlights
    
    7.4.3. Product Portfolio
    
    7.4.4. SWOT Analysis
    
    7.4.5. Key Strategies and Developments
    

      7.5. Corium International#Inc.
    

        7.5.1. Company Overview
    
    7.5.2. Financial Highlights
    
    7.5.3. Product Portfolio
    
    7.5.4. SWOT Analysis
    
    7.5.5. Key Strategies and Developments
    

      7.6. Johnson and Johnson
    

        7.6.1. Company Overview
    
    7.6.2. Financial Highlights
    
    7.6.3. Product Portfolio
    
    7.6.4. SWOT Analysis
    
    7.6.5. Key Strategies and Developments
    

      7.7. Alkermes plc
    

        7.7.1. Company Overview
    
    7.7.2. Financial Highlights
    
    7.7.3. Product Portfolio
    
    7.7.4. SWOT Analysis
    
    7.7.5. Key Strategies and Developments
    

      7.8. Pfizer#Inc.
    

        7.8.1. Company Overview
    
    7.8.2. Financial Highlights
    
    7.8.3. Product Portfolio
    
    7.8.4. SWOT Analysis
    
    7.8.5. Key Strategies and Developments
    

      7.9. Orbis Biosciences#Inc.
    

        7.9.1. Company Overview
    
    7.9.2. Financial Highlights
    
    7.9.3. Product Portfolio
    
    7.9.4. SWOT Analysis
    
    7.9.5. Key Strategies and Developments
    

      7.10. Capsugel
    

        7.10.1. Company Overview
    
    7.10.2. Financial Highlights
    
    7.10.3. Product Portfolio
    
    7.10.4. SWOT Analysis
    
    7.10.5. Key Strategies and Developments
    

      7.11. Merck and Co.#Inc.
    

        7.11.1. Company Overview
    
    7.11.2. Financial Highlights
    
    7.11.3. Product Portfolio
    
    7.11.4. SWOT Analysis
    
    7.11.5. Key Strategies and Developments
    

      7.12. Aradigm Corporation
    

        7.12.1. Company Overview
    
    7.12.2. Financial Highlights
    
    7.12.3. Product Portfolio
    
    7.12.4. SWOT Analysis
    
    7.12.5. Key Strategies and Developments
    

    8. Assumptions and Acronyms
    
9. Research Methodology
    
10. Contact
  • Inquiry Before Buying

    Inquiry Form

  • Request Sample

    Request for Sample

Related Reports

Office Address
Prudour Pvt. Ltd. 420 Lexington Avenue Suite 300 New York City, NY 10170.